Watson - Top 10 Generic Drug Companies 2010

WatsonCompany name: Watson Pharma
Location: Corona, CA (corporate) and Morristown, NJ (commercial)
Annual sales (in millions): $2.000
Market share: 6.3%
CEO: Paul Bisaro

Allen Chao and David Hsia started Watson in 1984. Chao wanted to pay tribute to his mother, whose maiden name was Hwa. The new company was named in her honor--with a small concession to the English language--"Hwa's son" becomes Watson, the company's website notes.    

Watson recently reported that during the second quarter, net revenue grew 29 percent ($875.3 million versus $677.8 million in the second quarter 2009). On an adjusted cash basis, net income increased 22 percent to $102.8 million or $0.83 per share, compared with $84.2 million or $0.73 per share in the second quarter 2009.

"We continue to emphasize growing our businesses through product development and portfolio and market expansion. In the U.S., we have launched five new generic products so far this year and announced twelve new patent challenges," says Paul Bisaro, Watson's president and CEO. "Outside the U.S., we continue to focus on enhancing our management structure, the profitability of our country operations, and expanding our presence in all of our markets including Finland, Poland and Turkey." In addition, the company announced that Sigurdur Oli Olafsson, who, until recently, was CEO of the Actavis group, is joining the company at the end of the year as VP of global generics.

Watson - Top 10 Generic Drug Companies 2010
Read more on

Suggested Articles

That didn’t take long. Sanofi CEO Paul Hudson has only been at the reins for a couple months, but on Tuesday, he unveiled a major shakeup.  

New "gold standard" data could further increase doctors' confidence in multiple myeloma med Darzalex, Johnson & Johnson says.

Could Monday's cancer buyout be a hint about what Sanofi CEO Paul Hudson will unveil at Tuesday's investor confab? Analysts think so.